🇬🇧CBD-Grousshandel zu Groussbritannien

The UK follows a logic unique in Europe: what counts is not a THC percentage but the "exempt product" rule — at most 1 mg of controlled cannabinoids per container. Raw flowers and resins remain controlled drugs regardless of content; only extracts have a legal channel, with ingestibles required to appear on the FSA's public list. The first British Novel Food authorisations are expected in the course of 2026 — the market is institutionalising. (EN)

Haaptpunkten

• Janvier 2019 — The FSA classifies CBD as a novel food: prior authorisation required for any ingestible product.
• 13 février 2020 — The FSA freezes the market: no new ingestible products without authorisation; existing products tolerated if an application was filed by 31 March 2021 — birth of the Public List.
• Octobre 2023 — The FSA lowers its recommended daily intake from 70 mg to 10 mg of CBD for a healthy adult.
• Août 2025 — Public consultation on the first three authorisation applications, with a favourable FSA recommendation; the final decision rests with ministers.

Quellen : FSA — Cannabidiol (CBD) guidance (mise à jour avril 2026) · GOV.UK — Consultation pack on applications for authorisation of 3 CBD food products as novel foods

Fir d'lescht gepréift: 2026-07